Clinical Trial Update: Narlumosbart Compared With Denosumab in Patients With Multiple Myeloma Bone Disease [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Narlumosbart with Denosumab in multiple myeloma bone disease is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Diseases
• Multiple Myeloma

Drugs mentioned

• Denosumab (denosumab)
• Narlumosbart

Snippet

Sponsor: RenJi Hospital | Conditions: Multiple Myeloma, Bone Diseases | Phase 3 | Status: NOT_YET_RECRUITING